169 related articles for article (PubMed ID: 34111706)
1. Primary high-grade myoepithelial carcinoma of the lung: A study of three cases illustrating frequent SMARCB1-deficiency and review of the literature.
Agaimy A; Naroditsky I; Ben-Izhak O
Ann Diagn Pathol; 2021 Aug; 53():151759. PubMed ID: 34111706
[TBL] [Abstract][Full Text] [Related]
2. Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts.
Skálová A; Agaimy A; Vanecek T; Baněčková M; Laco J; Ptáková N; Šteiner P; Majewska H; Biernat W; Corcione L; Eis V; Koshyk O; Vondrák J; Michal M; Leivo I
Am J Surg Pathol; 2021 Jan; 45(1):1-13. PubMed ID: 33027073
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
[TBL] [Abstract][Full Text] [Related]
4. Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Antonescu CR
Genes Chromosomes Cancer; 2016 Oct; 55(10):767-76. PubMed ID: 27218413
[TBL] [Abstract][Full Text] [Related]
5. Myoepithelioma-like Tumors of the Vulvar Region: A Distinctive Group of SMARCB1-deficient Neoplasms.
Yoshida A; Yoshida H; Yoshida M; Mori T; Kobayashi E; Tanzawa Y; Yasugi T; Kawana K; Ishikawa M; Sugiura H; Maeda D; Fukayama M; Kawai A; Hiraoka N; Motoi T
Am J Surg Pathol; 2015 Aug; 39(8):1102-13. PubMed ID: 26171919
[TBL] [Abstract][Full Text] [Related]
6. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
7. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
[TBL] [Abstract][Full Text] [Related]
8. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients.
Savera AT; Sloman A; Huvos AG; Klimstra DS
Am J Surg Pathol; 2000 Jun; 24(6):761-74. PubMed ID: 10843278
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.
Agaimy A; Koch M; Lell M; Semrau S; Dudek W; Wachter DL; Knöll A; Iro H; Haller F; Hartmann A
Am J Surg Pathol; 2014 Sep; 38(9):1274-81. PubMed ID: 24832165
[TBL] [Abstract][Full Text] [Related]
10. Rhabdoid Variant of Myoepithelial Carcinoma, with EWSR1 Rearrangement: Expanding the Spectrum of EWSR1-Rearranged Myoepithelial Tumors.
Thway K; Bown N; Miah A; Turner R; Fisher C
Head Neck Pathol; 2015 Jun; 9(2):273-9. PubMed ID: 24993038
[TBL] [Abstract][Full Text] [Related]
11. A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements.
Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2020 Jun; 59(6):348-356. PubMed ID: 31994243
[TBL] [Abstract][Full Text] [Related]
12. EWSR1-fusion-negative, SMARCB1-deficient primary pulmonary myxoid sarcoma.
Agaimy A; Duell T; Morresi-Hauf AT
Pol J Pathol; 2017; 68(3):261-267. PubMed ID: 29363919
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases.
Jo VY; Antonescu CR; Zhang L; Dal Cin P; Hornick JL; Fletcher CD
Am J Surg Pathol; 2013 May; 37(5):710-8. PubMed ID: 23588365
[TBL] [Abstract][Full Text] [Related]
14. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
[TBL] [Abstract][Full Text] [Related]
15. INI1-deficient tumors: diagnostic features and molecular genetics.
Hollmann TJ; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
[TBL] [Abstract][Full Text] [Related]
16. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
[TBL] [Abstract][Full Text] [Related]
17. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
Yin X; Yang X; Wang S; Zhou J; Zhao M
Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
[TBL] [Abstract][Full Text] [Related]
18. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
19. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
[TBL] [Abstract][Full Text] [Related]
20. Myxoepithelioid tumour with chordoid features: a clinicopathological, immunohistochemical and genetic study of 14 cases of SMARCB1/INI1-deficient soft-tissue neoplasm.
Kinoshita I; Kohashi K; Yamamoto H; Yamada Y; Inoue T; Higaki K; Teramoto N; Oshiro Y; Nakashima Y; Oda Y
Histopathology; 2021 Oct; 79(4):629-641. PubMed ID: 33932047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
